Milk-alkali syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
Nabeel ahmed (talk | contribs) |
Nabeel ahmed (talk | contribs) No edit summary |
||
| Line 11: | Line 11: | ||
*In 1915, Sippy designed an antacid regimen to neutralize gastric acidity and promote the healing of peptic ulcer disease . | *In 1915, Sippy designed an antacid regimen to neutralize gastric acidity and promote the healing of peptic ulcer disease . | ||
*The regimen included the hourly administration of milk or cream with Sippy powders (a powder containing 600 mg of magnesium carbonate and 600 mg sodium bicarbonate alternating with a powder containing 600 mg of bismuth subcarbonate and 1200 to 1800 mg of sodium bicarbonate) | *The regimen included the hourly administration of milk or cream with Sippy powders (a powder containing 600 mg of [[magnesium carbonate]] and 600 mg [[sodium bicarbonate]] alternating with a powder containing 600 mg of [[bismuth subcarbonate]] and 1200 to 1800 mg of sodium bicarbonate) | ||
*Toxic reactions associated with alkalosis and renal insufficiency were noted shortly thereafter, but the plasma calcium concentration was not measured. | *Toxic reactions associated with [[alkalosis]] and [[renal insufficiency]] were noted shortly thereafter, but the plasma calcium concentration was not measured. | ||
*In 1936, a report associated hypercalcemia with the alkalosis and renal failure in patients treated with the Sippy regime.<ref name="pmid7891547">{{cite journal |vauthors=Beall DP, Scofield RH |title=Milk-alkali syndrome associated with calcium carbonate consumption. Report of 7 patients with parathyroid hormone levels and an estimate of prevalence among patients hospitalized with hypercalcemia |journal=Medicine (Baltimore) |volume=74 |issue=2 |pages=89–96 |date=March 1995 |pmid=7891547 |doi= |url=}}</ref> | *In 1936, a report associated hypercalcemia with the alkalosis and renal failure in patients treated with the Sippy regime.<ref name="pmid7891547">{{cite journal |vauthors=Beall DP, Scofield RH |title=Milk-alkali syndrome associated with calcium carbonate consumption. Report of 7 patients with parathyroid hormone levels and an estimate of prevalence among patients hospitalized with hypercalcemia |journal=Medicine (Baltimore) |volume=74 |issue=2 |pages=89–96 |date=March 1995 |pmid=7891547 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 22:21, 22 April 2019
|
Milk-alkali syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Milk-alkali syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Milk-alkali syndrome historical perspective |
|
Risk calculators and risk factors for Milk-alkali syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Eponym
It is named for Charles Hoyt Burnett.[1][2]
Discovery
- There is limited information about the historical perspective of milk-alkali syndrome.
- In 1915, Sippy designed an antacid regimen to neutralize gastric acidity and promote the healing of peptic ulcer disease .
- The regimen included the hourly administration of milk or cream with Sippy powders (a powder containing 600 mg of magnesium carbonate and 600 mg sodium bicarbonate alternating with a powder containing 600 mg of bismuth subcarbonate and 1200 to 1800 mg of sodium bicarbonate)
- Toxic reactions associated with alkalosis and renal insufficiency were noted shortly thereafter, but the plasma calcium concentration was not measured.
- In 1936, a report associated hypercalcemia with the alkalosis and renal failure in patients treated with the Sippy regime.[3]
References
- ↑ Template:WhoNamedIt
- ↑ Burnett CH, Commons RR, Albright F, Howard JE (1949). "Hypercalcemia without hypercalcuria or hypophosphatemia, calcinosis and renal insufficiency; a syndrome following prolonged intake of milk and alkali". N. Engl. J. Med. 240 (20): 787–94. PMID 18126919.
- ↑ Beall DP, Scofield RH (March 1995). "Milk-alkali syndrome associated with calcium carbonate consumption. Report of 7 patients with parathyroid hormone levels and an estimate of prevalence among patients hospitalized with hypercalcemia". Medicine (Baltimore). 74 (2): 89–96. PMID 7891547.